The U.S. Anti-Doping Agency (USADA) can confirm that Floyd Mayweather and Manny Pacquiao have agreed to take part in the USADA testing program for their professional boxing fight scheduled for Saturday, May 2 in Las Vegas, Nevada. Both fighters have agreed to the rules established under the World Anti-Doping Code (Code), the World Anti-Doping Agency (WADA) Prohibited List, and the USADA Protocol for Olympic and Paralympic Movement Testing.
“It’s a strong statement of the importance of clean and safe competition to have these two fighters voluntarily agree to have a WADA level anti-doping program implemented for this fight. We commend them for their stand for clean sport and the message it sends to all those who want to compete clean at the highest levels of all sport,” said USADA CEO Travis T. Tygart.
Both fighters have already received education on the USADA program and have enrolled in the USADA Registered Testing Pool by providing their whereabouts information so that they can be located for out-of-competition testing prior to the fight. USADA will also perform in-competition testing after the fight. Both fighters agreed to be subject to both blood and urine testing without reservation. Samples collected by USADA are sent to a WADA-accredited laboratory for analysis in accordance with the world’s best laboratory practices including testing for human growth hormone (HGH), erythropoietin (EPO), and utilizing carbon isotope ratio (CIR).
USADA and the Nevada State Athletic Commission (NSAC) are working collaboratively on this program and will share all relevant information about the program including all test results. WADA will also be notified of all sample test results.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
For more information or media inquiries, click here.